SCIT Versus TAR for Outpatients With Schizophrenia
Comparative Effectiveness of Social Cognition and Interaction Training Program (SCIT) Versus Training of Affect Recognition Program (TAR) for Outpatients With Schizophrenia.
1 other identifier
interventional
100
0 countries
N/A
Brief Summary
The present work consists of a randomized clinical trial comparing the effectiveness of two interventions based on social cognition training in outpatients with schizophrenia. The investigators sought to compare the effect of a "targeted" (TAR) and a "broad-based" (SCIT) intervention on schizophrenia patients' performance in facial affect recognition, theory of mind and attributional style. Secondarily, the investigators compare the effect on symptomatology, general cognition and functioning. The main hypothesis was that the patient group receiving TAR would exhibit a greater improvement in emotion recognition performance at the post-intervention assessment in comparison to patients receiving the SCIT, and, conversely, patients receiving SCIT would show more effect in ToM and attributional style. To assess the durability of these effects, performance in measures of social cognition, basic cognitive functioning, symptomatology and functional capacity were assessed before (T0), after treatment (T1) and 3 months later (T2).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable schizophrenia
Started Sep 2013
Typical duration for not_applicable schizophrenia
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
June 30, 2017
CompletedFirst Submitted
Initial submission to the registry
October 20, 2017
CompletedFirst Posted
Study publicly available on registry
February 27, 2018
CompletedFebruary 27, 2018
February 1, 2018
3.1 years
October 20, 2017
February 20, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Face emotion recognition
Emotion recognition was measured with the Penn Emotion Recognition-40 (ER40) task, in which participants are asked to judge, one at a time, which emotion is shown on a series of 40 faces (Kohler et al, 2003).
24 weeks
Secondary Outcomes (3)
Theory of Mind
24 weeks
Attributional Style
24 weeks
Functioning
24 weeks
Study Arms (2)
SCIT Social cognition interactive
EXPERIMENTALPsychosocial intervention based on the Spanish translation of the original SCIT (Social Cognition and Interaction Training) instruction manual (Combs \& Penn; Lahera \& Benito, in press).
TAR Training in affect recognition
ACTIVE COMPARATORTraining in Affect Recognition it is a 12-session training on facial affect recognition over a period of 6 weeks.
Interventions
SCIT is a 18 weekly sessions lasting 45-60 minutes per session. The group will include 8-12 patients, with 2 therapists. The content of the sessions is based on the Spanish translation of the original SCIT (Social Cognition and Interaction Training) instruction manual (Combs, Adams, et al., 2007); (G. Lahera et al., 2013). The manual of the program developed for the improvement of emotional perception skills, attributional style and theory of mind in people with schizophrenia.
TAR is a 12-session training on facial affect recognition over a period of 6 weeks. Treatment includes one therapist (psychiatrist or clinical psychologist) and 2 patients. It involves neuropsychological strategies, such as restitution and compensation, as well as principles of errorless learning, direct positive reinforcement, verbalization and self-instruction (Frommann et al., 2003; Wölwer et al., 2005).
Eligibility Criteria
You may qualify if:
- Outpatients who met DSM-IV criteria for schizophrenia and schizoaffective disorder (SCID-P; First et al. 1994)
- Clinical stability: without any psychiatric hospitalizations in the last 3 months, with the same antipsychotic medication during the previous 6 weeks, and no planned change in the drug regime for the next 3 months.
- Age in the range from 18 to 65 years
You may not qualify if:
- Disorders other than schizophrenia or schizoaffective disorder, according to DSM-IV diagnosis criteria;
- Additional axis-I or axis-II diagnosis;
- Dependence to alcohol or other drugs (except nicotine);
- Serious somatic disorders or organic brain damage;
- Mental retardation or difficulty speaking or understanding the Spanish language.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- Trained raters who were blind to treatment condition assessed participants on the following variables at baseline, post-treatment and 3-month follow-up
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- M.D., Ph.D. Assistant Professor of Psychiatry
Study Record Dates
First Submitted
October 20, 2017
First Posted
February 27, 2018
Study Start
September 1, 2013
Primary Completion
October 1, 2016
Study Completion
June 30, 2017
Last Updated
February 27, 2018
Record last verified: 2018-02
Data Sharing
- IPD Sharing
- Will not share